Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated
document and the Japanese original, the original shall prevail.

Consolidated Financial Results
for the Nine Months Ended June 30, 2024
[Japanese GAAP]
August 8, 2024
Company name: Fuji Pharma Co.,Ltd.
Listing: Tokyo
Securities code: 4554
URL: https://www.fujipharma.jp/
Representative: Takayuki Iwai

President & CEO
Executive Corporate Officer,General & Manager, Corporate
Planning Department

Inquiries: Takeshi Sato
Telephone: +81-3-3556-3344Scheduled date to commence dividend payments: Preparation of supplementary material on financial results: Yes
Holding of financial results briefing: None

(Yen amounts are rounded down to millions, unless otherwise noted.)
1. Consolidated Financial Results for the Nine Months Ended June 30, 2024 (October 1, 2023 to June 30, 2024)(1) Consolidated Operating Results(Percentages indicate year-on-year changes.)
Profit attributable toNet sales
Operating profit
Ordinary profit
owners of parent% Millions of yen% Millions of yen% Millions of yen%
Millions of yen
Nine months ended
June 30, 2024
33,15512.5
2,215(7.8)
2,967
8.3
4,910
147.7
June 30, 2023
29,48211.4
2,403(33.5)
2,741(28.4)
1,982(25.0)(Note) Comprehensive income:Nine months ended June 30, 2024:¥4,729 million [(14.4) %]Nine months ended June 30, 2023:¥
5,525 million [53.4%]
Basic earnings
per share
Nine months ended
June 30, 2024
June 30, 2023

Diluted earnings pershare
Yen

Yen

201.9881.58-(2) Consolidated Financial Position
Total assets
Millions of yen
As ofJune 30, 2024
88,478September 30, 2023
85,332(Reference) Equity: As of June 30, 2024:
As of September 30, 2023:

Net assets

Capital adequacy ratio

Millions of yen¥¥

144,960
41,17744,956 million
41,174 million

%

50.8
48.3

2. Dividends
Annual dividends
1stquarter-end

2ndquarter-end

3rdquarter-end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended September 30, 2023

-

17.00

-

20.00

37.00

Fiscal year ending September 30, 2024

-

20.00

22.50

42.50

Year-end

Fiscal year ending September 30, 2024
(Forecast)(Note) Revision to the forecast for dividends announced most recently:
None(Note) Breakdown of the 3rd quarter dividend for the fiscal year ending September 30, 2024 :Commemorative dividend- yenSpecial dividend
- yen

Total

3. Consolidated Financial Results Forecast for the Fiscal Year Ending September 30, 2024(October 1, 2023 to September 30, 2024)(Percentages indicate year-on-year changes.)
Profit attributable to Basic earnings
Net sales
Operating profit
Ordinary profit
owners of parent
per share
Millions of yen% Millions of yen% Millions of yen

46,060
12.6
3,990
3.4Full year
(Note) Revision to the financial results forecast announced most recently:* Notes:(1) Significant changes in the scope of consolidation during the period:
Newly included:(Company name:
Excluded:(Company name:

4,602
None% Millions of yen

1.8

6,185%

Yen

80.0

254.51None))(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements:(3) Changes in accounting policies, changes in accounting estimates, and restatement
1) Changes in accounting policies due to revisions to accounting standards and other regulations:
2) Changes in accounting policies due to other reasons: None
3) Changes in accounting estimates: None
4) Restatement: NoneNoneNone(4) Number of issued shares (common shares)
1) Total number of issued shares at the end of the period (including treasury shares):
June 30, 2024:
24,753,800 shares
September 30, 2023:
24,753,800 shares
2) Number of treasury shares at the end of the period:
June 30, 2024:
441,510 shares
September 30, 2023:
450,992 shares
3) Average number of shares outstanding during the period:
Nine months ended June 30, 2024:
Nine months ended June 30, 2023:

24,309,984 shares
24,300,823 shares* Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public
accountants or an audit firm: None
* Proper use of earnings forecasts, and other special matters2

Quarterly Consolidated Financial Statements
Quarterly Consolidated Balance Sheets(Millions of yen)
As of September 30, 2023
AssetsCurrent assets
Cash and deposits
Notes receivable - trade
Accounts receivable - trade
Merchandise and finished goods
Work in process
Raw materials and supplies
Advance payments to suppliers
Accounts receivable - other
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant and equipment
Buildings and structures, net
Machinery, equipment and vehicles, net
Land
Leased assets, net
Construction in progress
Other, net
Total property, plant and equipment
Intangible assets
Goodwill
Sales rights
Other
Total intangible assets
Investments and other assets
Investment securities
Long-term advance payments
Deferred tax assets
Other
Total investments and other assets
Total non-current assets
Total assets

3

As of June 30, 2024

2,324
1,116
15,1885,138
3,861
10,372
166
216
730
(0)
39,1142,704
1,111
16,453
6,128
3,875
10,150
509
47
867
(0)
41,848

10,230
3,233
1,105
3,216
2,102
658
20,547

10,137
2,887
1,264
5,519
645
706
21,161

412
9,343
737
10,493

175
9,655
707
10,53910,587
2,300
475
1,813
15,177
46,21885,332

8,176
3,348
642
2,761
14,92946,62988,478(Millions of yen)
As of September 30, 2023
Liabilities
Current liabilities
Notes and accounts payable - tradeShort-term borrowings
Current portion of bonds payable
Current portion of long-term borrowings
Lease liabilities
Income taxes payable
Provision for bonuses
Provision for bonuses for directors (and otherofficers)
Other
Total current liabilities
Non-current liabilities
Bonds payable
Long-term borrowings
Lease liabilities
Retirement benefit liability
Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders' equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total shareholders' equity
Accumulated other comprehensive income
Valuation difference on available-for-salesecurities
Deferred gains or losses on hedges
Foreign currency translation adjustment
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets

4

As of June 30, 2024

5,672
11,300
600
4,610
514
484
872

6,129
13,500
600
6,850
1,460
1,228
490

118

5,704
29,771

4,298
34,566

2,100
6,583
3,241
1,863
595
14,38344,155

1,500
133
4,845
2,038
434
8,951
43,5183,799
4,409
29,082(567)36,723

3,799
4,409
33,032(553)
40,686

2,414

1,637

2
1,996
37
4,451
2
41,177
85,332

44
2,555
32
4,269
3
44,96088,478

Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statements of Income (For the nine months)(Millions of yen)
For the nine months
ended June 30, 2023
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating profit
Non-operating income
Interest income
Foreign exchange gains
Contributed income
Gain on valuation of derivatives
OtherTotal non-operating income
Non-operating expenses
Interest expenses
Bond issuance costs
Other
Total non-operating expenses
Ordinary profit
Extraordinary income
Gain on sale of investment securities
ContributedIncome
Total extraordinary income
Extraordinary losses
Loss on tax purpose reduction entry of non-current
assetsLoss on disaster
Total extraordinary losses
Profit before income taxes
Income taxes - current
Income taxes - deferred
Total income taxes
ProfitProfit attributable to non-controlling interests
Profit attributable to owners of parent

5For the nine months
ended June 30, 2024

29,482
17,95611,526
9,123
2,403

33,155
20,642
12,512
10,296
2,215

147
110
177
102
440

3
29765
107
905

79
14
8
102
2,741

137
15
153
2,967

-

3,118
835
3,953-

60

2,741
592
165
758
1,982
0
1,982

40
101
6,819
1,743
166
1,909
4,910
0
4,910

Quarterly Consolidated Statements of Comprehensive Income (For the nine months)(Millions of yen)
For the nine months
ended June 30, 2023
ProfitOther comprehensive income
Valuation difference on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustmentRemeasurements of defined benefit plans, net of tax
Total other comprehensive income
Comprehensive income
Comprehensive income attributable toComprehensive income attributable to owners ofparent
Comprehensive income attributable to non-controllinginterests

6

For the nine months
ended June 30, 2024
1,982

4,910

3,022
2520
(2)
3,543
5,525

(776)
41559
(5)
(180)
4,729

5,525

4,729

00